Contact Details
Professor Deborah White is Executive Director of SAHMRI and an internationally recognised cancer researcher with extensive experience in precision medicine, genomics and scientific leadership.
Professor White’s work has focused on improving outcomes for people with acute lymphoblastic leukaemia (ALL), particularly through genomics and targeted therapies. She has led multidisciplinary teams of scientists and bioinformaticians seeking to better understand the genetic drivers of leukaemia and translate these discoveries into more precise approaches to treatment.
Prior to becoming Executive Director, Professor White was co-lead of SAHMRI’s Precision Cancer Medicine Theme for four years. She has also held senior roles in major national cancer and genomics initiatives, including Australian Genomics and the Zero Childhood Cancer Program, and contributed to collaborations spanning childhood and adult leukaemia and precision medicine.
Find out more about Deborah's research outputs, qualifications and affiliations on the
SAHMRI Researcher portal
ALL-IMMUNE Late-Effects Study
Project Status: IN PROGRESS
